Award for Excellence in Medication Safety ASHP Foundation and Cardinal Health Foundation

Transcription

1 Award for Excellence in Medication Safety ASHP Foundation and Cardinal Health Foundation Barbara B. Nussbaum, B.S. Pharm., Ph.D. Vice President, ASHP Foundation

2 Webinar Agenda Housekeeping Award Program History What s New and Always Important Highlights of Criteria and Submission Process Who is eligible and not eligible? What is the submission process? How is a submission evaluated? What are examples of past winning initiatives? Information & Online Application Program Timeline Questions

3 ASHP Foundation Philanthropic arm of ASHP Mission: To improve the health and wellbeing of patients in health systems through appropriate, safe and effective medication use. Cardinal Health Foundation The Cardinal Health Foundation supports local, national, and international programs that improve healthcare quality and build healthy communities.

4 Award Program History Nationally Acclaimed Awards Program Conceptualized in 2003 by leaders from ASHP, Cardinal Health and both Foundations Intent: Showcase the Critical Value of Pharmacist Leadership to Achieve Meaningful Impact on Medication Safety and Improved Outcomes.

5 The Goals of the Program: Recognize continuous quality improvement initiatives within the medication-use system that are large in scope, have demonstrated impact on patient safety and care, and are applicable to other healthcare systems; Award outstanding pharmacist leadership on multidisciplinary teams; and Disseminate the results of these initiatives in order to enhance the spread and implementation of medication safety best practices.

6 What s New and Important New for 2018 Priority Topics Antimicrobial Stewardship Opioid Stewardship Initiatives that span the care continuum Always Important Demonstrated impact on patients and the organization Multidisciplinary team

7 Who is Eligible? Not-for-profit organizations, for-profit entities, and government agencies are eligible to apply to this program. Note: If a for-profit entity or government agency is a recipient or finalist, the monetary award must be received and managed by a 501(c)3 not-for-profit organization. The institution must be in the United States of America. The hospital or health system must be licensed by the state in which it is located and be accredited by an appropriate regulatory body such as The Joint Commission. Continued

8 Who is Not Eligible? Previous recipients and finalists of this award program are not eligible for the ensuing five years after they were recognized as a recipient or finalist (e.g., the 2016 recipient and finalists would be eligible to apply in 2021). Members of the ASHP Foundation Board of Directors and the ASHP Board of Directors cannot be on a team applying for this program. Note: If you become one of the three finalists in the 2018 program, we ask that you not submit to the 2018 ASHP Best Practices Awards program. You are welcome to submit to the ASHP Best Practices program in a subsequent year.

9 What is the submission process? Step 1: Letter of Intent Applicants are required to submit a letter of intent (LOI) that describes their medication safety initiative. Letters of intent will be reviewed by external expert reviewers. Only the top-ranked applicants will be invited to submit a full application and program narrative. LOI Deadline: January 5, 2018

10 Letter of Intent Instructions A concise description, not to exceed 1000 words, of your institution s medication safety initiative should be provided in the letter of intent. Required Section Headings: 1. Medication-Use System Initiative Scope 2. Pharmacist Leadership 3. Planning and Implementation 4. Measured Outcomes and Impact 5. Innovation and Generalizability 6. Sustainability and Advancement Tip: Refer to Evaluation Criteria when developing LOI

11 Step 2: Invited Full Application Submission The initiative description may not exceed ten (10) pages, including the abstract, (using 11-point font or larger, 8.5 x 11 inch paper, 1-inch margins, single spacing and single-sided pages). All graphs, charts, and references should not exceed five pages in the appendices. Full Application Deadline: March 22, 2018

12 How is a submission evaluated? Criteria & Scoring Points Required Element 0 Abstract 0 10 Medication Use System Initiative Scope 0 15 Pharmacist Leadership 0 10 Planning and Implementation 0 35 Measured Outcomes and Impact 0 20 Innovation and Generalizability 0 10 Sustainability and Advancement

13 Selection Criteria Medication-Use System Initiative Scope (10 points) Baseline Data to Support Quantifiable with reliable baseline data Data significant and compelling evidence of a medication safety challenge that required performance improvement Hospital/System-wide Broad in nature Important Multiple components of the system

14 Selection Criteria Pharmacist Leadership (15 points) Pharmacist Leadership Throughout: Role in identifying the underlying medication safety problem. Led planning and implementation of the medication safety improvement initiative. Role in analyzing outcome data, communicating results and assessing institutional impact.

15 Selection Criteria Planning and Implementation (10 points) Multidisciplinary: The medication safety improvement initiative was implemented by a multidisciplinary team. Comprehensive: Initiative was well-designed and based on comprehensive plans and timetables. Continued

16 Selection Criteria Planning and Implementation (10 points) Barriers: Planning process was developed to identify barriers to implementation and respond to those barriers. Communication/Education: Implementation plan included processes for communicating with and educating staff about the implementation of the medication safety improvement initiative.

17 Selection Criteria Measured Outcomes and Impact (35 points) Data demonstrates a positive impact on the medication safety problem or challenge that required performance improvement. Patient-centered safety, therapeutic, humanistic and/or economic outcomes. Show evidence of reductions in morbidity, mortality, preventable adverse drug events, inpatients lengths of stay, hospital readmissions, emergency department visits and/or overall costs of care.

18 Selection Criteria Innovation and Generalizability (20 points) Innovation: New technology, technique, process, service. Demonstrated innovative approach to the use of resources (e.g., dollars, staff time, techniques, and tools). Generalizable: The components of the medication safety improvement initiative can be adopted in other hospitals/health-systems or throughout a state. The results of the initiative have been communicated to other health professionals and healthcare organizations.

19 Selection Criteria Sustainability and Advancement (10 points) Sustainable: Evidence is provided that the medication safety improvement initiative can be sustained in the institution over the long term. Advancement: Specific ideas are included to advance the activities and initiative.

20 Examples of Previous Recipients BJC HealthCare, Missouri Using Automation to Detect Severe Hypoglycemia, Collect Causative Factors and Inform Prevention Strategies Across a Large Health Care System Yale-New Haven Hospital, Connecticut Moving Oncology Care Closer to Home: Pharmacy Leadership Makes a Difference Houston Methodist Hospital System Clinical Management of High-Risk Medication Use to Mitigate the Incidence of Hospital-Acquired Delirium in the Geriatric Population

21 More Examples All previous recipients are listed on the ASHP Foundation website: rds/awardforexcellenceinmedicationusesafety.aspx

22 Electronic Application Submission

23 Program Timeline Letter of Intent Deadline January 5, 2018 Letter of Intent External Review January to Early February Applicants Notified of Status Mid February Full Application Deadline (Invited) March 22 External Review Online and Review Call April to Early May Virtual Project Presentations (Invited) June Top 3 Site Visits July Recipient and up to 2 Finalists Selected August Award Presentation at December 2018 ASHP Midyear Meeting

24 Questions? Contact: